Skip to content
10-Q

Quarterly Report

GENOMIC HEALTH, INC.

0001558370-18-006583

← back to feed
Filed
Aug 7, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jul 31, 2018 35.86M sh
Cash And Equivalents Q2 2018 · Jun 30, 2018 $53.85M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $45.52M
Current Liabilities Q2 2018 · Jun 30, 2018 $39.99M
Current Liabilities Q2 2018 · Dec 31, 2017 $39.52M
Current Assets Q2 2018 · Jun 30, 2018 $215.38M
Current Assets Q2 2018 · Dec 31, 2017 $174.26M
Total Assets Q2 2018 · Jun 30, 2018 $269.02M
Total Assets Q2 2018 · Dec 31, 2017 $231.62M
Revenue Q2 2018 · Jun 30, 2018 $95.62M
Revenue Q2 2018 · Jun 30, 2018 $188.24M
Revenue Q2 2018 · Jun 30, 2017 $85.49M
Revenue Q2 2018 · Jun 30, 2017 $169.47M
Shares Diluted Q2 2018 · Jun 30, 2017 34.43M sh
Shares Diluted Q2 2018 · Jun 30, 2017 34.22M sh
Capex Q2 2018 · Jun 30, 2017 $8.06M
Operating Cash Flow restated Q2 2018 · Jun 30, 2017 $11.9M
Eps Diluted Q2 2018 · Jun 30, 2017 −$0.08
Eps Diluted Q2 2018 · Jun 30, 2017 −$0.10
Eps Basic Q2 2018 · Jun 30, 2017 −$0.08
Eps Basic Q2 2018 · Jun 30, 2017 −$0.10
Sga Expense Q2 2018 · Jun 30, 2017 $18.4M
Sga Expense Q2 2018 · Jun 30, 2017 $35.15M
Rd Expense Q2 2018 · Jun 30, 2017 $15.78M
Rd Expense Q2 2018 · Jun 30, 2017 $30.66M
Net Income Q2 2018 · Jun 30, 2017 −$2.74M
Net Income Q2 2018 · Jun 30, 2017 −$3.55M
Operating Income Q2 2018 · Jun 30, 2017 −$3.14M
Operating Income Q2 2018 · Jun 30, 2017 −$5.97M
Cost Of Revenue Q2 2018 · Jun 30, 2017 $13.8M
Cost Of Revenue Q2 2018 · Jun 30, 2017 $27.47M